Anton Giorgio Failla
Network origin in Anton Giorgio Failla first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 21 | |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Phenomix Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. It's internally discovered product candidates are designed to have improved efficacy, safety or convenience relative to existing therapies and other product candidates in clinical development. Its lead product candidate, dutogliptin tartrate, is a dipeptidyl peptidase-4, or DPP-4, inhibitor that it is developing as an oral, once-daily treatment for Type 2 diabetes. Its Phase 2b clinical trial of dutogliptin demonstrated statistically significant reductions in HbA1c when administered in combination with existing drugs for the treatment of Type 2 diabetes. The company commenced its Phase 3 clinical program in the third quarter of 2008. Its second product candidate, PHX1766, is a protease inhibitor currently in Phase 1 of clinical development for the treatment of hepatitis C virus, or HCV, infection. The company intends to maximize the value of its product candidates through independent development, licensing and other partnership opportunities. These may include co-development or co-marketing agreements, licensing agreements with pharmaceutical and biotechnology companies that possess established development and commercialization capabilities or direct commercialization by building its own sales and marketing force.
20
| Extinct | Pharmaceuticals: Major | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anton Giorgio Failla via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| LIFECORE BIOMEDICAL, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
LJL Biosystems, Inc.
 LJL Biosystems, Inc. Medical DistributorsDistribution Services LJL BioSystems, Inc. develops, designs, produces and sells infrastructure tools for drug discovery. Its products are used in the discovery process of screening and genotyping. It serves pharmaceutical, biotechnology and genomics companies as well as research institutions. The company is located in Sunnyvale, CA. | Medical Distributors | Director/Board Member Director/Board Member | |
| INTERMUNE INC | Biotechnology | Director/Board Member General Counsel | |
Inveresk Research Group, Inc.
 Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director/Board Member Director/Board Member | |
BioMarck Pharmaceuticals Ltd.
 BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Antipodean Pharmaceuticals, Inc.
 Antipodean Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Antipodean Pharmaceuticals, Inc. manufactures pharmaceutical products and provides pre clinical services. Its product MitoQ, which blocks mitochondrial oxidative damage and prevents cell death. The company was founded in 2002 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer Chairman Director of Finance/CFO Public Communications Contact General Counsel | |
Wildcat Discovery Technologies, Inc.
 Wildcat Discovery Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Wildcat Discovery Technologies, Inc. provides commercial research and development services. The firm engages in development projects for materials for other applications, including gas storage, carbon capture, thermoelectric, and structural materials. Its products include electrolyte additives such as EM1, CM1, CM2, and EM2. The company was founded by Peter G. Schultz and Robert K. Downs in 2006 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Afraxis, Inc.
 Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Founder | |
| ZENITH CAPITAL CORP. | Biotechnology | Chief Executive Officer | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Rice University | College/University | Undergraduate Degree Undergraduate Degree | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Chairman | |
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Pharmaceuticals: Major | Chairman Director/Board Member General Counsel | |
| Wake Forest University | College/University | Doctorate Degree Undergraduate Degree | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Doctorate Degree Director/Board Member | |
| University of Connecticut | College/University | Undergraduate Degree Masters Business Admin | |
| AMBRX INC | Pharmaceuticals: Major | Founder Chairman | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Founder Corporate Officer/Principal | |
Panorama Capital LLC
 Panorama Capital LLC Investment ManagersFinance Panorama Capital LLC (Panorama Capita) is a venture capital firm founded in 1995 by Chris Albinson, Rod Ferguson, Shahan Soghikian and damion wicker. The firm is headquartered in Campbell, California. | Investment Managers | Founder Chief Investment Officer Private Equity Analyst | |
Averion International Corp.
 Averion International Corp. Miscellaneous Commercial ServicesCommercial Services Averion International Corp. provides clinical research services. It serves for pharmaceutical, biotechnology and medical device industries. The company mainly focuses on oncology, nephrology, dermatology and medical devices. The company was founded on April 22, 2002 and is headquartered in Southborough, MA. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Chiesi Hellas Pharmaceuticals SA
 Chiesi Hellas Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Chiesi Hellas Pharmaceuticals SA provides research, development and sale of medicinal products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It offers solutions for the treatment of asthma and chronic obstructive pulmonary disease. The company is headquartered in Vrilissa, Greece. | Pharmaceuticals: Major | Director/Board Member | |
| Carolina Pharmaceuticals, Inc. | Chief Executive Officer Corporate Officer/Principal | ||
Chiesi Ltd.
 Chiesi Ltd. Electronic Equipment/InstrumentsElectronic Technology Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| Chiesi Pharmaceuticals (Pvt) Ltd. | Director/Board Member | ||
| Chiesi Pharmaceuticals, Inc. | Director/Board Member Corporate Secretary | ||
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
Chiesi SA (Belgium)
 Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| TERRASCEND CORP. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member |
Statistics
International
| United States | 41 |
| Canada | 3 |
| Denmark | 2 |
| Australia | 2 |
| Italy | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 5 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 260 |
| Corporate Officer/Principal | 124 |
| Independent Dir/Board Member | 73 |
| Chief Executive Officer | 36 |
| President | 33 |
Most connected contacts
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 54 |
| Daniel Janney | 47 |
| Deepa Pakianathan | 32 |
| Julie Cherrington | 32 |
| John Diekman | 29 |
| Michael Heffernan | 23 |
| Peter G. Schultz | 21 |
| Marco Vecchia | 19 |
| Craig Collard | 18 |
| Laura Shawver | 18 |
| D. W. E. Wicker | 16 |
| Andrew Powell | 16 |
| Robert M. Stephan | 16 |
| Brian Dickson | 15 |
| Girish Putcha | 14 |
- Stock Market
- Insiders
- Anton Giorgio Failla
- Company connections
